Bray, George A.

A 6‐Month Randomized, Placebo‐Controlled, Dose‐Ranging Trial of Topiramate for Weight Loss in Obesity

Bray, G. A., Hollander, P., Klein, S., Kushner, R., Levy, B., Fitchet, M., & Perry, B. H. (2003) · Obesity Research

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 344

Clinical Efficacy of Orlistat Therapy in Overweight and Obese Patients With Insulin-Treated Type 2 Diabetes

Kelley, D. E., Bray, G. A., Pi-Sunyer, F. X., Klein, S., Hill, J., Miles, J., & Hollander, P. (2002) · Diabetes Care

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 314

Lifestyle change and mobility in obese adults with type 2 diabetes

Rejeski, W. J., Ip, E. H., Bertoni, A. G., Bray, G. A., Evans, G., Gregg, E. W., & Zhang, Q. (2012) · New England Journal of Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsPhysical Activity and Health

Cited by 301

Effect of Dietary Protein Content on Weight Gain, Energy Expenditure, and Body Composition During Overeating: A Randomized Controlled Trial

Bray, G. A., Smith, S. R., de Jonge, L., Xie, H., Rood, J., Martin, C. K., Most, M., Brock, C., Mancuso, S., & Redman, L. M. (2012) · JAMA

Regulation of Appetite and ObesityMuscle metabolism and nutrition

Cited by 285

The prevention of type 2 diabetes

F. T. D. P. P. R. G., Crandall, J. P., Knowler, W. C., Kahn, S. E., Marrero, D., Florez, J. C., Bray, G. A., Haffner, S. M., Hoskin, M., & Nathan, D. M. (2008) · Nature Clinical Practice Endocrinology & Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 261

Obesity, A Disorder Of Nutrient Partitioning: The MONA LISA Hypothesis

Bray, G. A. (1991) · The Journal of Nutrition

Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic Diseases

Cited by 243

American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease

Garvey, W. T., Garber, A. J., Mechanick, J. I., Bray, G. A., Dagogo-Jack, S., Einhorn, D., Grunberger, G., Handelsman, Y., Hennekens, C. H., Hurley, D. L., et al. (2014) · Endocrine Practice

Obesity and Health PracticesObesity, Physical Activity, Diet

Cited by 238

Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor

Ukropcova, B., McNeil, M., Sereda, O., de Jonge, L., Xie, H., Bray, G. A., & Smith, S. R. (2005) · Journal of Clinical Investigation

Metabolism, Diabetes, and CancerAdipose Tissue and Metabolism

Cited by 213

Beyond BMI

Bray, G. A. (2023) · Nutrients

Body Composition Measurement TechniquesObesity, Physical Activity, Diet

Cited by 210

Diurnal variation in glucose tolerance. Cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects

Lee, A., Ader, M., Bray, G. A., & Bergman, R. N. (1992) · Diabetes

Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 193

Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial

de Souza, R. J., Bray, G. A., Carey, V. J., Hall, K. D., LeBoff, M. S., Loria, C. M., Laranjo, N. M., Sacks, F. M., & Smith, S. R. (2012) · The American Journal of Clinical Nutrition

Diet and metabolism studiesNutritional Studies and Diet

Cited by 192

Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial

Heianza, Y., Sun, D., Li, X., DiDonato, J. A., Bray, G. A., Sacks, F. M., & Qi, L. (2019) · Gut

Gut microbiota and healthNutritional Studies and Diet

Cited by 177

Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial

Smith, S. R., de Jonge, L., Volaufova, J., Li, Y., Xie, H., & Bray, G. A. (2005) · Metabolism

Diabetes Treatment and ManagementPeroxisome Proliferator-Activated Receptors

Cited by 176

Association of body mass with dietary restraint and disinhibition

WILLIAMSON, D. A., LAWSON, O. J., BROOKS, E. R., WOZNIAK, P. J., RYAN, D. H., BRAY, G. A., & DUCHMANN, E. G. (1995) · Appetite

Eating Disorders and BehaviorsNutrition, Health and Food Behavior

Cited by 168

Family History of Diabetes Links Impaired Substrate Switching and Reduced Mitochondrial Content in Skeletal Muscle

Ukropcova, B., Sereda, O., de Jonge, L., Bogacka, I., Nguyen, T., Xie, H., Bray, G. A., & Smith, S. R. (2007) · Diabetes

Adipose Tissue and MetabolismMetabolism, Diabetes, and Cancer

Cited by 165

Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study

Bray, G. A. (2006) · Diabetes and Vascular Disease Research

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 158

Evidence‐based weight loss interventions: Individualized treatment options to maximize patient outcomes

Bray, G. A., & Ryan, D. H. (2021) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 148

Relationship between resting metabolic rate and the composition of the fat-free mass

Sparti, A., DeLany, J. P., de la Bretonne, J. A., Sander, G. E., & Bray, G. A. (1997) · Metabolism

Body Composition Measurement TechniquesRegulation of Appetite and Obesity

Cited by 129

Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

Diabetes Prevention Program Research Group, Nathan, D. M., Knowler, W. C., Edelstein, S., Crandall, J. P., Dabelea, D., Goldberg, R. B., Kahn, S. E., Mather, K. J., Trandafirescu, G., et al. (2019) · Diabetes Care

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 128

Effects of Weight Loss, Weight Cycling, and Weight Loss Maintenance on Diabetes Incidence and Change in Cardiometabolic Traits in the Diabetes Prevention Program

Delahanty, L. M., Pan, Q., Jablonski, K. A., Aroda, V. R., Watson, K. E., Bray, G. A., Kahn, S. E., Florez, J. C., Perreault, L., Franks, P. W., et al. (2014) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsObesity, Physical Activity, Diet

Cited by 125

Medical treatment of obesity: The past, the present and the future

Bray, G. A. (2014) · Best Practice & Research Clinical Gastroenterology

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 109

Prevention of Diabetes With Pioglitazone in ACT NOW

DeFronzo, R. A., Tripathy, D., Schwenke, D. C., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S. C., Gastaldelli, A., Henry, R. R., Kitabchi, A. E., et al. (2013) · Diabetes

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 109

The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial

Johnson, K. C., Bray, G. A., Cheskin, L. J., Clark, J. M., Egan, C. M., Foreyt, J. P., Garcia, K. R., Glasser, S., Greenway, F. L., Gregg, E. W., et al. (2017) · Journal of Bone and Mineral Research

Bone health and osteoporosis researchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 104

Pioglitazone Slows Progression of Atherosclerosis in Prediabetes Independent of Changes in Cardiovascular Risk Factors

Saremi, A., Schwenke, D. C., Buchanan, T. A., Hodis, H. N., Mack, W. J., Banerji, M., Bray, G. A., Clement, S. C., Henry, R. R., Kitabchi, A. E., et al. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 101